ABCC7 p.Glu822Lys

ClinVar: c.2464G>A , p.Glu822Lys ? , not provided
c.2464G>T , p.Glu822* D , Pathogenic
CF databases: c.2464G>T , p.Glu822* D , CF-causing
c.2464G>A , p.Glu822Lys (CFTR1) ? , A nucleotide change, G->A was observed in exon 13 at position 2596 leading to E822K. The patient is 13 years old, and pancreatic insufficient. The other mutation is still unknown. This mutation was found once among 28 Belgian CF chromosomes.
Predicted by SNAP2: A: D (53%), C: D (66%), D: D (66%), F: D (75%), G: D (71%), H: D (71%), I: D (63%), K: N (61%), L: D (66%), M: D (71%), N: D (71%), P: D (80%), Q: D (59%), R: D (75%), S: D (66%), T: D (63%), V: D (59%), W: D (80%), Y: D (75%),
Predicted by PROVEAN: A: N, C: D, D: N, F: D, G: N, H: N, I: D, K: N, L: D, M: D, N: N, P: N, Q: N, R: N, S: N, T: N, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Frelet A, Klein M
Insight in eukaryotic ABC transporter function by mutation analysis.
FEBS Lett. 2006 Feb 13;580(4):1064-84. Epub 2006 Jan 19., 2006-02-13 [PMID:16442101]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Ostedgaard LS, Baldursson O, Vermeer DW, Welsh MJ, Robertson AD
A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution.
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5657-62., 2000-05-09 [PMID:10792060]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Xie J, Adams LM, Zhao J, Gerken TA, Davis PB, Ma J
A short segment of the R domain of cystic fibrosis transmembrane conductance regulator contains channel stimulatory and inhibitory activities that are separable by sequence modification.
J Biol Chem. 2002 Jun 21;277(25):23019-27. Epub 2002 Apr 11., 2002-06-21 [PMID:11950844]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Bobadilla JL, Macek M Jr, Fine JP, Farrell PM
Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.
Hum Mutat. 2002 Jun;19(6):575-606., [PMID:12007216]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Rowntree RK, Harris A
The phenotypic consequences of CFTR mutations.
Ann Hum Genet. 2003 Sep;67(Pt 5):471-85., [PMID:12940920]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Green DM, McDougal KE, Blackman SM, Sosnay PR, Henderson LB, Naughton KM, Collaco JM, Cutting GR
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
Respir Res. 2010 Oct 8;11:140., [PMID:20932301]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Vankeerberghen A, Wei L, Jaspers M, Cassiman JJ, Nilius B, Cuppens H
Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator.
Hum Mol Genet. 1998 Oct;7(11):1761-9., [PMID:9736778]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Tan AL, Ong SA, Venkatesh B
Biochemical implications of sequence comparisons of the cystic fibrosis transmembrane conductance regulator.
Arch Biochem Biophys. 2002 May 15;401(2):215-22., [PMID:12054472]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Wei L, Vankeerberghen A, Cuppens H, Droogmans G, Cassiman JJ, Nilius B
Phosphorylation site independent single R-domain mutations affect CFTR channel activity.
FEBS Lett. 1998 Nov 13;439(1-2):121-6., [PMID:9849891]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Chen JM, Scotet V, Ferec C
Definition of a "functional R domain" of the cystic fibrosis transmembrane conductance regulator.
Mol Genet Metab. 2000 Sep-Oct;71(1-2):245-9., [PMID:11001817]

Abstract [show]
Comments [show]
Sentences [show]